Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial

Nom du journal : Lancet Oncol

Année : 2016

Volume : 17

Page de départ : 1070

Page de fin : 1080

Auteurs: Piperno-Neumann S, Le Deley MC, Pacquement H, Marec-Bérard P, Petit P, Brisse H, Lervat C, Gentet JC, Entz-Werlé N, Italiano A, Corradini N, Bompas E, Penel N, Tabone MD, Gomez-Brouchet A, Guinebretière JM, Mascard E, Gouin F, Chevance A, Bonnet N, Blay JY, Brugières L, on behalf of the Sarcoma Group of UNICANCER, the French Society of Pediatric Oncology (SFCE) and the French Sarcoma Group (GSF-GETO), the French Society of Pediatric Oncology (SFCE) and the French Sarcoma Group (GSF-GETO),